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The connection between the heart and the gut 
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CLINICAL PROBLEM: A 45-year old male with ulcerative colitis was admitted with bloody 
diarrhoea and chest pain. Inflammatory markers and high-sensitivity troponin were elevated 
(CRP 57 mg/L, WBC 10.65 109/L, Neutrophil 6.6 109/L, TnI 663 mmol/L). The 
electrocardiogram (ECG) showed inferior ST- elevation. Urgent coronary angiography 
revealed unobstructed coronary arteries. Inpatient cardiovascular magnetic resonance 
(CMR) was arranged to determine the aetiology of the myocardial infarction with non-
obstructive coronary arteries (MINOCA). The imaging protocol at 1.5 T included balanced 
steady state free precession (bSSFP) cine images, T2-weighted oedema sequences, early and 
late gadolinium enhancement (LGE). Native T1 and T2 mapping images provided advanced 
tissue characterisation.  
 
QUESTION: What is the most likely diagnosis based on the MRI findings?  
A) Multiple embolic myocardial infarctions in the right coronary artery territory  
B) Acute autoimmune myocarditis  
C) Cardiac sarcoidosis  
D) Stress (Takotsubo) cardiomyopathy  
E) Multiple embolic myocardial infarctions in the left circumflex coronary artery territory  
 
ANSWER: B) Multiple patchy, mid-myocardial, high-intensity signal areas in the inferolateral 
wall on T2 weighted images (B) and increased T2 mapping values on the short axis images 
(G) are highly specific for oedema. These areas have high-signal intensity on early (C) and 
late (D,H) sequences, suggesting hyperaemia with capillary leakage and increased 
extracellular space, respectively. Furthermore, increased native T1 mapping values in all 
layers but predominantly in the subepicardium of the entire lateral wall (F) are in keeping 
with extensive myocardial injury. Taken in combination, these findings meet the updated 
Lake Louise criteria for acute myocarditis (1) . Despite extensive oedema, stress (Takotsubo) 
cardiomyopathy (Option D) can be excluded by ventricular morphology and presence of LGE 
(2), and multiple embolic myocardial infarctions (Option A and E) are excluded by the non-
ischemic pattern of LGE  (3). Finally, based on the CMR, cardiac sarcoidosis (Option C) 
cannot be easily distinguished from acute autoimmune myocarditis. However, the clinical 
presentation and  absence of pulmonary changes make the latter diagnosis the most likely 
(4). Cardiac biopsy might definitively differentiate, but is not routinely performed due to 
associated procedural risk. The patient was treated with corticosteroids and monoclonal 
antibodies and responded well. The pathophysiological mechanisms underlying cardiac 
manifestations of inflammatory bowel disease are incompletely understood but may occur 
in up to one third of patients with inflammatory bowel disease (5). 
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